Bard Peripheral Vascular Inc GlidePath Long-Term Hemodialysis Catheter with Preloaded Stylet, REF/Product code:5393190, 14.5F, Straight, 19cm length, BARD, UDI: 00801741012174 Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
GlidePath Long-Term Hemodialysis Catheter with Preloaded Stylet, REF/Product code:5393190, 14.5F, Straight, 19cm length, BARD, UDI: 00801741012174
Brand
Bard Peripheral Vascular Inc
Lot Codes / Batch Numbers
(Lot #, Exp.) REDN2496 9/30/2020, REDN0142 7/31/2020, RECZ1104 7/31/2020, RECZ0651 4/30/2020, RECW2475 3/31/2020, RECX0509 3/31/2020, RECX1199 4/30/2020, RECW1846 3/31/2020, RECW0961 9/30/2020, RECW0095 8/31/2020, RECX1120 7/31/2020, RECV1690 7/31/2020
Products Sold
(Lot #, Exp.) REDN2496 9/30/2020; REDN0142 7/31/2020; RECZ1104 7/31/2020; RECZ0651 4/30/2020; RECW2475 3/31/2020; RECX0509 3/31/2020; RECX1199 4/30/2020; RECW1846 3/31/2020; RECW0961 9/30/2020; RECW0095 8/31/2020; RECX1120 7/31/2020; RECV1690 7/31/2020
Bard Peripheral Vascular Inc is recalling GlidePath Long-Term Hemodialysis Catheter with Preloaded Stylet, REF/Product code:5393190, 14.5F, St due to The action is being initiated due to complaints received concerning the molded tip of the tunneler breaking or is damaged during the placement proced. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
The action is being initiated due to complaints received concerning the molded tip of the tunneler breaking or is damaged during the placement procedure of the catheter.
Recommended Action
Per FDA guidance
Bard Peripheral Vascular, Inc. (BPV) mailed a recall letter on May 23, 2019 to each of the US consignees via FedEx with proof of delivery notification. BPV is also issuing customer notifications for product outside the US in accordance with regulations of each country in which the product was distributed. The recall letter asked consignees to do the following: 1. Do not use or further distribute any affected product. 2. Please check all inventory locations within your institution for affected product code / lot number combinations listed in the recall notice. If you have further distributed any of the product code / lot numbers, please immediately contact that location, advise them of the recall, forward these instructions and have them return the affected product to BPV. 3. Please remove any identified product from your shelves. 4. If you have used the affected product, complete and return the attached Recall and Effectiveness Check Form indicating no product will be returned. Once the product affected by this recall has been removed from your inventory: 5. Fill out the Recall and Effectiveness Check Form. Be sure to state the quantities and lot numbers of each recalled product that you intend to return. It is extremely important that we receive this information. 6. Please call our BPV Customer Support Center at 1-800-321-4254 Option #5 (M-F 5am to 2pm MST) or email at BDPI.CustomerSupportCenter@bd.com. Once all information has been verified, the BPV Customer Support Center will issue you a Return Authorization (XC) Number to facilitate the expedient return of the product. BPV will issue a replacemnt product for your returned product. 7. Email the completed Recall and Effectiveness Check Form to BDPI.CustomerSupportCenter@bd.com or fax it to BPV at 1-800-994-6772. If you cannot email or FAX the form, please call the BPV Customer Support Center at 1-800-321-4254 Option #5 and report the required information verbally. 8. A mailing labe
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV, WI, WY, DC, PR
Page updated: Jan 10, 2026